“Digital health is by nature not limited to national borders.”
Hein van den Bos
As the UK negotiates its new relationship with the European Union, the provision of crossborder healthcare as well as the development and regulation of medical technology pose important questions. Hein van den Bos, Counsel at Hogan Lovells, provides commentary on the objectives of the Brexit negotiations for the UK and the EU, and considers how and why both sides will look to continue collaborating to develop digital health without border restrictions.
Lees hier het volledige artikel.
Hein van den Bos is ook gequoot in Bloomberg: 'Europe’s Drug Regulator Is Backing Away From the U.K.'